A detailed history of West End Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, West End Advisors, LLC holds 2 shares of BIIB stock, worth $312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$312
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

BUY
$253.3 - $285.89 $506 - $571
2 New
2 $0
Q2 2022

Jul 28, 2022

BUY
$187.54 - $223.02 $187 - $223
1 Added 100.0%
2 $407,000
Q2 2021

Jul 15, 2021

BUY
$259.0 - $414.71 $259 - $414
1 New
1 $346,000
Q2 2019

Jul 23, 2019

SELL
$219.29 - $241.72 $24.1 Million - $26.6 Million
-109,859 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $351,286 - $549,454
1,621 Added 1.5%
109,859 $26 Billion
Q4 2018

Jan 30, 2019

BUY
$278.5 - $352.75 $972,800 - $1.23 Million
3,493 Added 3.33%
108,238 $32.6 Billion
Q3 2018

Nov 07, 2018

SELL
$293.51 - $383.83 $5.54 Million - $7.24 Million
-18,868 Reduced 15.26%
104,745 $37 Billion
Q2 2018

Jul 26, 2018

SELL
$257.52 - $306.91 $2.36 Million - $2.82 Million
-9,174 Reduced 6.91%
123,613 $35.9 Billion
Q1 2018

May 08, 2018

SELL
$260.13 - $367.91 $1.45 Million - $2.05 Million
-5,561 Reduced 4.02%
132,787 $36.4 Billion
Q4 2017

Feb 02, 2018

SELL
$307.64 - $344.58 $12.5 Million - $14 Million
-40,710 Reduced 22.74%
138,348 $44.1 Billion
Q3 2017

Nov 03, 2017

SELL
$281.15 - $329.69 $2.97 Million - $3.49 Million
-10,572 Reduced 5.58%
179,058 $56.1 Billion
Q2 2017

Aug 09, 2017

BUY
N/A
189,630
189,630 $51.5 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.